Treatment options for children with hemophilia A have expanded with the FDA approval of Bayer's Jivi antihemophilic factor ...

The company said the discontinuation was due to several reasons,” Reuters news service reported, “including limited interest ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...